期刊文献+

乳腺癌保乳术后全乳逆向IMRT对腋窝Ⅰ—Ⅲ站及前哨淋巴结剂量覆盖评估 被引量:5

Dose coverage of axillary levels Ⅰ-Ⅲ and sentinel lymph node area by inverse-planned intensity-modulated radiotherapy for whole breast irradiation in patients with breast cancer after breast-conserving surgery
原文传递
导出
摘要 目的 评估早期乳腺癌保乳术后全乳逆向IMRT对腋窝Ⅰ、Ⅱ、Ⅲ站及前哨淋巴结区域的剂量覆盖情况.方法 回顾分析2008-2012年间在复旦大学附属肿瘤医院接受保乳手术及前哨淋巴结活检术的40例乳腺癌患者临床资料.术后全乳逆向IMRT处方剂量为50 Gy分25次.按照RTOG标准及术中放置钛夹的位置勾画腋窝Ⅰ、Ⅱ、Ⅲ站及前哨淋巴结区域,并分析相应区域受量.结果 腋窝Ⅰ、Ⅱ、Ⅲ站淋巴结的平均剂量分别为(33.0±7.5)、(17.9±11.3)、(7.3±6.6)Gy,V9s分别为(29.9±17.7)%、(9.0±14.5)%、(0.1±0.3)%.所有前哨淋巴结均位于第Ⅰ站腋窝淋巴结区域,前哨淋巴结的平均剂量为(43.0±10.0) Gy,58% (19/33)的平均剂量>45 Gy.结论 采用逆向IMRT照射乳腺时,腋窝Ⅰ、Ⅱ、Ⅲ站淋巴结受量有限,对前哨淋巴结微转移且未清扫腋窝者应充分考虑这一因素. Objective To evaluate the dose coverage of axillary levels Ⅰ-Ⅲ and the sentinel lymph node (SLN) area by multi-field inverse-planned intensity-modulated radiotherapy (IMRT) for whole breast irradiation in patients with early breast cancer after breast-conserving surgery.Methods A retrospective analysis was performed on the clinical data of 40 patients with early breast cancer who underwent breastconserving surgery and SLN biopsy in Fudan University Shanghai Cancer Center from 2008 to 2012.After surgery,inverse-planned IMRT for whole breast irradiation was performed at a dose of 50 Gy/25 fractions.The axillary levels Ⅰ-Ⅲ were delineated according to the RTOG criteria,and the SLN CTV was defined as 2 cm in diameter around the clip.Dose-volume parameters were used to calculate the dose distribution of these lymph node areas.Results The mean doses delivered to axillary levels Ⅰ,Ⅱ,and Ⅲ were (33.0 ± 7.5) Gy,(17.9 ± 11.3) Gy,and (7.3 ±6.6) Gy,respectively.The percent volumes receiving at least 95% of the prescribed dose for axillary levels Ⅰ,Ⅱ,and Ⅲ were (29.9 ± 17.7) %,(9.0 ± 14.5) %,and (0.1 ±0.3) %,respectively.All SLNs were located in axillary level Ⅰ area; the mean dose received by the SLN area was (43.0 ± 10.0) Gy,and 58% (19/33) of SLNs received a dose greater than 45 Gy.Conclusions The multi-field inverse-planned IMRT offers a limited dose coverage to axillary levels Ⅰ-Ⅲ in patients receiving inverse-planned IMRT for whole breast irradiation.For those patients with SLN micrometastases and without axillary lymph node dissection,we need to keep an eye on the dose coverage of the axillary area.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2014年第6期468-471,共4页 Chinese Journal of Radiation Oncology
基金 国家自然科学基金面上项目(81372430) 上海市卫生局局级科研项目(2010021)
关键词 乳腺肿瘤/放射疗法 逆向调强放射疗法 腋窝淋巴结 前哨淋巴结 Breast neoplasms/radiotherapy Inverse-planned intensity modulated radiotherapy Axillary levels Sentinel lymph node
  • 相关文献

参考文献24

  • 1Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011 [ J]. J Clin Oncol, 2007,25:3657-3663. 被引量:1
  • 2Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial [ J]. JAMA, 2011,305:569-575. 被引量:1
  • 3Giuliano hE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial [J]. Ann Surg,2010,252:426-432,432-433. 被引量:1
  • 4Haffty BG, Hunt KK, Harris JR, et al. Positive sentinel nodes without axillary dissection:implications for the radiation oncologist [ J]. J Clin Oncol,2011,29:4479-4481. 被引量:1
  • 5Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01 ) :a phase 3 randomised controlled trial [ J]. Lancet Oneol,2013,14:297-305. 被引量:1
  • 6White J, Tai A, Arthur D, et al. Breast cancer atlas for radiation therapy planning: consensus definitions [ DB/OL] [2014-02-20]. http ://www. rtog. org/CoreLab/ContouringAtlases/ BreastCancerAtlas. aspx. 被引量:1
  • 7A1-Ghazal SK, Fallowfield L, Blamey RW. Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? [ J]. Eur J Surg Oncol, 1999,25 : 571- 573. 被引量:1
  • 8Veldeman L, Madani I, Hulstaert F, et al. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies [ J]. Lancet Oncol,2008,9:367-375. 被引量:1
  • 9Mukesh MB, Barnett GC, Wilkinson JS, et al. Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer:5-year results confirm superior overall cosmesis [J]. J Clin Onco1,2013 ,31:4488-4495. 被引量:1
  • 10Krasin M, McCall A, King S, et al. Evaluation of a standard breast tangent technique: a dose-volume analysis of tangential irradiation using three-dimensional tools [ J]. Int J Radiat Oncol Biol Phys ,2000,47:327-333. 被引量:1

同被引文献66

  • 1Winnie K.W. So,Gene Marsh,W.M. Ling,F.Y. Leung,Joe C.K. Lo,Maggie Yeung,George K.H. Li.Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy[J]. European Journal of Oncology Nursing . 2009 (1) 被引量:1
  • 2P?ivi Salonen,Pirkko-Liisa Kellokumpu-Lehtinen,Marja-Terttu Tarkka,Anna-Maija Koivisto,Marja Kaunonen.Changes in quality of life in patients with breast cancer. Journal of Clinical Nursing . 2011 被引量:2
  • 3Farid Saleh,Abdallah Behbehani,Sami Asfar.Abnormal Blood Levels of Trace Elements and Metals, DNA Damage, and Breast Cancer in the State of Kuwait. Biological Trace Element Research . 2011 被引量:1
  • 4Morton DL,Wen DR,Wong JH,et al. Technical details of intraoperative lymphatic mapping for early stage melanoma[J].Arch Surg,1992,127(4):392-399.DOI:10.1001/archsurg.1992.01420040034005. 被引量:1
  • 5Albertini JJ,Lyman GH,Cox C,et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer[J].JAMA,1996,276(22):1818-1822.DOI:10.1001/jama.1996.03540220042028. 被引量:1
  • 6Veronesi U,Paganelli G,Viale G,et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer[J].N Engl J Med,2003,349(6):546-553.DOI:10.1056/NEJMoa012782. 被引量:1
  • 7Krag DN,Anderson SJ,Julian TB,et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer:overall survival findings from the NSABP B-32 randomised phase 3 trial[J].Lancet Oncol,2010,11(10):927-933.DOI:10.1016/S1470-2045(10)70207-2. 被引量:1
  • 8Lyman GH,Giuliano AE,Somerfield MR,et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J].J Clin Oncol,2005,23(30):7703-7720.DOI:10.1200/JCO.2005.08.001. 被引量:1
  • 9Giuliano AE,Hunt KK,Ballman KV,et al. Axillary dissection 与 no axillary dissection in women with invasive breast cancer and sentinel node metastasis:a randomized clinical trial[J].JAMA,2011,305(6):569-575.DOI:10.1001/jama.2011.90. 被引量:1
  • 10Galimberti V,Cole BF,Zurrida S,et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01):a phase 3 randomised controlled trial[J].Lancet Oncol,2013,14(4):297-305.DOI:10.1016/S1470-2045(13)70035-4. 被引量:1

引证文献5

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部